Insider · CIK 0001411726

Evans Daron

Reports to the SEC for 3 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001411726

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-02	RZLTRezolute, Inc.F Tax Payment	CFO	FTax Payment	−3,062 sh	$4.99	−$15.3K	411,400
2026-03-30	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+10K sh	$2.85	+$28.5K	414,462
2026-03-02	RZLTRezolute, Inc.F Tax Payment	CFO	FTax Payment	−11.4K sh	$2.99	−$34.2K	404,462
2025-12-15	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+40K sh	$1.77	+$70.6K	415,900
2025-12-15	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+2,500 sh	$1.78	+$4,462.5	7,000
2025-12-15	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+2,500 sh	$1.79	+$4,475	7,000
2025-12-09	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+10.5K sh	$5.04	+$53.2K	131,900
2025-11-19	RZLTRezolute, Inc.A Award	CFO	AAward	+107K sh	—	—	375,900
2025-11-19	RZLTRezolute, Inc. · Employee Stock Option (Right to Buy)A Award	CFO	AAward	+63K sh	—	—	63,000
2025-06-24	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+5,000 sh	$4.05	+$20.3K	268,900
2025-06-10	RZLTRezolute, Inc. · Employee Stock Option (Right to Buy)A Award	CFO	AAward	+15K sh	—	—	15,000
2025-06-10	RZLTRezolute, Inc.A Award	CFO	AAward	+26K sh	—	—	263,900
2025-03-26	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+10K sh	$2.88	+$28.8K	23,000
2025-03-26	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+10K sh	$2.89	+$28.9K	237,900
2025-02-16	RZLTRezolute, Inc.A Award	CFO	AAward	+77K sh	—	—	227,900
2025-02-16	RZLTRezolute, Inc. · Employee Stock Option (Right to Buy)A Award	CFO	AAward	+45K sh	—	—	45,000
2024-12-18	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+10K sh	$4.29	+$42.9K	150,900
2024-12-12	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+9,000 sh	$4.60	+$41.4K	140,900
2024-09-23	RZLTRezolute, Inc. · Employee Stock Option (Right to Buy)A Award	CFO	AAward	+100K sh	—	—	100,000
2024-06-14	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+40K sh	$4.04	+$162K	40,000
2024-05-29	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+451 sh	$3.50	+$1,578.5	121,351
2024-05-24	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+2,942 sh	$3.23	+$9,502.66	13,000
2024-05-23	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+58 sh	$2.85	+$165.3	10,058
2024-03-15	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+20K sh	$1.69	+$33.8K	20,000
2024-03-08	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+50K sh	$1.93	+$96.3K	120,900
2024-02-16	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+4,500 sh	$1.37	+$6,165	4,500
2024-02-16	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+41.9K sh	$1.30	+$54.4K	70,900
2024-02-16	RZLTRezolute, Inc.P Purchase	CFO	PPurchase	+4,500 sh	$1.37	+$6,165	4,500
2024-01-23	RZLTRezolute, Inc. · Employee Stock Option (Right to Buy)A Award	CFO	AAward	+275K sh	—	—	275,000
2021-05-27	NEPHNEPHROS INCF Tax Payment	CEO of Specialty Renal Product	FTax Payment	−349 sh	$2.70	−$942.3	8,669
2021-05-27	NEPHNEPHROS INCF Tax Payment	CEO of Specialty Renal Product	FTax Payment	−349 sh	$2.70	−$942.3	8,947
2021-05-24	NEPHNEPHROS INC · Common Stock Warrants (Right to Buy)X Exercise of In-Money	CEO of Specialty Renal Product	XExercise of In-Money	−1,111 sh	—	—	0
2021-05-24	NEPHNEPHROS INC · Common Stock Warrants (Right to Buy)X Exercise of In-Money	CEO of Specialty Renal Product	XExercise of In-Money	−1,111 sh	—	—	0
2021-05-24	NEPHNEPHROS INCX Exercise of In-Money	CEO of Specialty Renal Product	XExercise of In-Money	+1,111 sh	$2.70	+$2,999.7	9,018
2021-05-24	NEPHNEPHROS INCX Exercise of In-Money	CEO of Specialty Renal Product	XExercise of In-Money	+1,111 sh	$2.70	+$2,999.7	9,296
2020-03-12	NEPHNEPHROS INCP Purchase	CEO of Specialty Renal Product	PPurchase	+2,500 sh	$6.65	+$16.6K	134,215
2020-03-05	NEPHNEPHROS INCP Purchase	CEO of Specialty Renal Product	PPurchase	+2,500 sh	$8.44	+$21.1K	131,715
2020-02-01	NEPHNEPHROS INC · Stock Option (Right to Buy)A Award	CEO of Specialty Renal Product	AAward	+97.1K sh	—	—	242,690
2019-12-16	NEPHNEPHROS INC · Stock Option (Right to Buy)A Award	CEO of Specialty Renal Product	AAward	+20K sh	—	—	20,000
2019-12-16	NEPHNEPHROS INCA Award	CEO of Specialty Renal Product	AAward	+9,282 sh	—	—	129,215
2019-11-18	NEPHNEPHROS INCP Purchase	CEO of Specialty Renal Product	PPurchase	+1,000 sh	$8.35	+$8,350	119,933
2019-08-22	NEPHNEPHROS INCP Purchase	CEO of Specialty Renal Product	PPurchase	+2,000 sh	$6.92	+$13.8K	118,933
2019-08-09	NEPHNEPHROS INC · Stock Option (Right to Buy)A Award	CEO of Specialty Renal Product	AAward	+36.4K sh	—	—	145,614
2019-06-14	NEPHNEPHROS INCP Purchase	CEO of Specialty Renal Product	PPurchase	+8,000 sh	$0.60	+$4,829.6	8,000
2019-06-14	NEPHNEPHROS INCP Purchase	CEO of Specialty Renal Product	PPurchase	+8,000 sh	$0.61	+$4,875.2	8,000
2019-06-14	NEPHNEPHROS INCP Purchase	CEO of Specialty Renal Product	PPurchase	+8,000 sh	$0.59	+$4,720	71,166
2019-06-14	NEPHNEPHROS INCP Purchase	CEO of Specialty Renal Product	PPurchase	+8,000 sh	$0.58	+$4,652.8	73,666
2019-06-14	NEPHNEPHROS INCP Purchase	CEO of Specialty Renal Product	PPurchase	+11.2K sh	$0.60	+$6,683.09	1,052,426
2018-12-14	NEPHNEPHROS INCA Award	CEO of Specialty Renal Product	AAward	+108K sh	—	—	1,001,254
2018-05-14	NEPHNEPHROS INCX Exercise of In-Money	CEO of Specialty Renal Product	XExercise of In-Money	+40K sh	$0.30	+$12K	95,000

Recent filings

Accepted (ET)
Jul 74
Evans Daron0000912282-26-000929
SEC(opens sec.gov)
Mar 314
Evans Daron0000912282-26-000533
SEC(opens sec.gov)
Mar 44
Evans Daron0000912282-26-000411
SEC(opens sec.gov)
Dec 154
Evans Daron0000912282-25-001424
SEC(opens sec.gov)
Nov 214
Evans Daron0000912282-25-001292
SEC(opens sec.gov)
Jun 244
Evans Daron0000912282-25-000706
SEC(opens sec.gov)
Jun 124
Evans Daron0000912282-25-000661
SEC(opens sec.gov)
Mar 284
Evans Daron0000912282-25-000339
SEC(opens sec.gov)
Feb 194
Evans Daron0000912282-25-000180
SEC(opens sec.gov)
Dec 184
Evans Daron0000912282-24-000908
SEC(opens sec.gov)
Dec 124
Evans Daron0000912282-24-000884
SEC(opens sec.gov)
Dec 104
Evans Daron0000912282-24-000863
SEC(opens sec.gov)
Sep 244
Evans Daron0000912282-24-000673
SEC(opens sec.gov)
Jun 144
Evans Daron0000912282-24-000494
SEC(opens sec.gov)

Companies

Address

C/O REZOLUTE, INC. 275 SHORELINE DRIVE, SUITE 500

REDWOOD CITY, CA, 94065